FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns application of epidermal growth factor (EGF) for preparing an injected pharmaceutical composition wherein said composition is administered by infiltration on the periphery of nerve stems and/or ganglia for the purpose of the morphofunctional recovery of peripheral nerves in painful sensorimotor neuropathy accompanying ischemic neuritis. It also relates to a EGF-containing composition wherein this substance may be combined with anaesthetics and analgesics and encapsulated in microspheres.
EFFECT: invention provides reducing neuropathic pain relief.
20 cl, 5 ex, 2 dwg, 16 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION IN FORM OF MICROSPHERES FOR PREVENTION OF EXTREMITY AMPUTATION IN CASE OF DIABETES | 2007 |
|
RU2426528C2 |
| USING PHARMACEUTICAL COMPOSITION COMPRISING EPIDERMAL GROWTH FACTOR (EGF) FOR PREVENTION OF DIABETIC LIMB AMPUTATION | 2002 |
|
RU2289424C2 |
| GHRP-6-CONTAINING PHARMACEUTICAL COMPOSITION FOR PREVENTION AND REMOVAL OF FIBROSIS AND OTHER PATHOLOGICAL DEPOSITS IN TISSUES | 2007 |
|
RU2465913C2 |
| APPLICATION OF 3-HYDROXY-3-METHTYLGLUTARYL-COENZYME A REDUCTASE INHIBITORS IN PRODUCING MEDICINAL AGENT FOR TREATMENT OF DIABETIC NEUROPATHY | 2000 |
|
RU2239456C2 |
| USE OF SIGMA LIGANDS IN DIABETES TYPE-2 ASSOCIATED PAIN | 2012 |
|
RU2608943C2 |
| PREGNANDIONS OR PREGNANDIOLS APPLICATION AS NEUROPATHIC ANALGESIC AGENTS | 2002 |
|
RU2346690C2 |
| NEW PREVENTIVE AND/OR THERAPEUTIC MEDICATION AGAINST DIABETIC NEUROPATHY | 2008 |
|
RU2465906C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING ALDEHYDE REDUCTASE INHIBITOR AND ACE INHIBITOR | 1998 |
|
RU2216354C2 |
| N-[2-HYDROXY-3(1-PIPERIDINYL)-PROPOXY]-PYRIDINE-1-OXYDE-3- CARBOXYIMIDOYL CHLORIDE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND TREATMENT METHOD | 2000 |
|
RU2250901C2 |
| COMBINATION , CONTAINING HERB COMBINATION EXTRACT, FOR PREVENTION OR TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY | 2011 |
|
RU2566721C2 |
